Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
MOA of Carbamazepine
|
Inhibition of voltage-dependent sodium channels
|
|
MOA of Phenytoin
|
Inhibition of voltage-dependent sodium channels
|
|
MOA of Lamotrigine
|
Inhibition of voltage-dependent sodium channels
|
|
MOA of Oxcarbazepine
|
Inhibition of voltage-dependent sodium channels
|
|
MOA of Zonisamide
|
Inhibition of voltage-dependent sodium channels
|
|
MOA of Ethosuxamide
|
Inhibition of neuronal calcium channels
|
|
MOA of phenobarbital
|
Enhanced GABA activity
|
|
MOA of pentobarbital
|
Enhanced GABA activity
|
|
MOA of benzodiazepine
|
Enhanced GABA activity
|
|
MOA of Tiagabine
|
Enhanced GABA activity
|
|
MOA of valproate
|
inhibition of sodium channels and enhanced GABA activity
|
|
MOA of Topirimate
|
Inhibition of NMDA-glutamate receptors and enhanced GABA activity
|
|
Typical anti-seizure use of carbamazepine
|
Monotherapy for partial or generalized convulsive seizures
|
|
Typical anti-seizure use of phenytoin
|
monotherapy for partial or generalized convulsive seizures, status epilepticus
|
|
Typical anti-seizure use of Lamotrigine
|
Partial seuzres
Second-line for generalized convulsive seizures |
|
Typical anti-seizure use of Oxcarbazepine
|
Monotherapy for partial or generalized convulsive seizures
|
|
Typical anti-seizure use of Zonisamide
|
Second line for partial and generalized convulsive seizures
|
|
Typical anti-seizure use of ethosuxamide
|
Absence seizures
|
|
Typical anti-seizure use of barbiturates
|
Nonresponsive status epilepticus
|
|
Typical anti-seizure use ofBenzodiazepine
|
Status epilepticus
|
|
Typical anti-seizure use of Tiagabine
|
Second line drug for partial seizures
|
|
Typical anti-seizure use of Valproate
|
Monotherapy or second drug for partial and generalized seuzires
|
|
Typical anti-seizure use of topiramate
|
Second-line drug for partial and generalized seizures
|
|
Typical anti-seizure use of gabapentin
|
Monotherapy or second drug for partial seizure
|
|
Typical anti-seizure use of levatiracetam
|
monotherapy for partial seizres
Second-line drug for partial or generalized seuizres |
|
What is the treatment of choice for tension headaches?
|
NSAIDs
|
|
What is the treatment of choice for Cluster headaches?
|
100% O2 (6+ L/min on nonrebreather) for 20+ minutes
Sumatriptan or dihydroergotamine |
|
What is the treatment of choice for migraine headaches?
|
Sumatriptant, dihydroergotamine, NSAIDs, and/or antiemetics (though vasoconstrictors shouldn't be mixed)
|
|
MOA of Levodopa
|
Dopamine precursor
|
|
MOA of Carbidopa
|
Dopamine decarboxylase inhibitor - reduces rlevodopa metabolism
|
|
MOA of bromocriptine
|
Dopamine receptor agonist
|
|
MOA of Selegiline
|
MAO-B Inhibitor
|
|
MOA of Amantadine
|
Increases synthesis, release or reuptake of dopamine
|
|
MOA of benztropine
|
Blockade of cholinergic transmission
|
|
Indications for levodopa
|
Initial therapy for Parkinson's Disease
|
|
Indications for carbidopa
|
Parkinson's Disease - Combination therapy with levodopa
|
|
Indications for bromocriptine
|
Parkinson's Disease - increases response to levodopa in patient's with a declining response
|
|
Indications for Selegiline in Parkinson's disease
|
Used in early disease - may help delay need to start levodopa
|
|
Indications for Amantadine in Parkinson's disease
|
Used to treat rigidity and bradykinesia
|
|
Use of Valerian
|
OTC herbal used for Insomnia
Studies show no benefit |
|
Which patient populations should avoid the use of antihistamines for insomnia? Why?
|
Antihistamines
Anticholinergic side effects can be detrimental in the elderly (orthostasis, delirium) and can exacerbate dementia |
|
What is a common medication of choice in elderly patients with insomnia?
|
Trazodone
|
|
What is a common medication of choice for treatment of insomnia is depressed patients during the early phase of treatment (before antidepressant effect is realized)?
|
Benzodiazepines
|
|
What is the one medication that may slow progression of ALS?
|
Riluzole
|
|
MOA of Riluzole
|
Decreases glutamate-induced excitotoxicity
|